Feedback / Questions
APRTX-001 - Aperture Therapeutics
https://www.prnewswire.com/news-releases/aperture-therapeutics-announces-development-candidate-targeting-cd33-to-restore-microglial-homeostasis-in-ftd-and-als-302620390.html
Nov 19, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next